More fool them. I've near doubled my position in MSB under $2. The indications have not gone away and the company continues to secure its future via partnerships and strategic funding. Still think the market vastly underestimating the implications of the SurgeCenter investment beyond the cash. This report only confirms further the likelihood of a long and fruitful partnership with SurgCenter and other informed and involved partners.
Ann: Mesoblast Update on Chronic Low Back Pain Program, page-50
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
0.030(1.90%) |
Mkt cap ! $1.832B | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.65 | $1.59 | $7.014M | 4.343M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 342 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.61 | 54534 | 8 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |